Search clinical trials for: stent thrombosis

Total 6691 results

Sahajanand Medical Technologies Pvt. Ltd.

Terminated

Infinnium-Core™ Registry for the Treatment of Patients With De Novo Coronary Lesions

Coronary Artery Disease

India
Sahajanand Medical Technologies Pvt. Ltd.
Cardialysis BV

Terminated

SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent

Coronary Artery Disease

India, Brazil, Saudi Arabia
Sahajanand Medical Technologies Pvt. Ltd.
Cardiovascular Research Center, Brazil

Completed

The E-SERIES Registry for Supralimus® Coronary Stent for the Treatment of Unselected Patients With Coronary Lesions

Coronary Artery Disease

Brazil
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study (XIENCE V India)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

India
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Association of Clopidogrel Therapy and Stent Thrombosis (REAL-LATE)

Coronary Artery Disease

Korea, Republic of
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN Sub-study

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

Italy, Norway, Switzerland, Denmark, Spain, Poland, Belgium, Argentina, Austria, Brazil, France, Germany, Hungary, Latvia, Netherlands
Abbott Medical Devices

Completed

Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR (List of Reimbursable Products and Services) Indications in Patients Monitored for 2 Years in France (Far XIENCE V®)

Coronary Artery Disease

France
Abbott Medical Devices

Completed

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United States, Australia, New Zealand, Germany
Abbott Medical Devices

Completed

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Myocardial Ischemia | Coronary Artery Disease | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Stents | Total Coronary Occlusion | Coronary Artery Restenosis

United States
Gilard, Martine
Abbott Medical Devices; Clinical Research Organization and study management

Unknown

Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogrel (ITALICplus)

Restenosis

France
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation (ABSORB A)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Denmark, Poland, Netherlands
Tampere University
Boston Scientific Corporation

Completed

Prospective Clinical Observational Registry Including Consecutive Patients With In-stent Restenosis or Stent Thrombosis (NIVUS)

Restenosis | Stent Thrombosis

Norway, Sweden, Denmark, Finland, Latvia
St. Antonius Hospital
University of Cologne

Completed

Platelet Reactivity in Stent Thrombosis Patients (MAPCAT)

Coronary Artery Stent Thrombosis

Netherlands
Samsung Medical Center
Medtronic

Completed

The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent (DATE)

Coronary Artery Disease

Korea, Republic of
Careggi Hospital

Completed

REsponsiveness to CLOpidogrel and Stent-related Events in Acute Coronary Syndromes (RECLOSE 2 - ACS) (RECLOSE2-ACS)

Stent Thrombosis | Platelet Function | Antiplatelet Therapy | Acute Cardiac Syndrome

Italy
Abbott Medical Devices

Completed

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System (SPIRIT II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Spain, Denmark, Germany, France, Austria, Belgium, India, Italy, New Zealand, Poland, South Africa, Switzerland
Fundació Institut de Recerca de l'Hospital de la...

Unknown

Late Incomplete Stent Apposition Evaluation II: Comparison Between Polimer-based and No-polimer Stent System. IVUS Based Study (LISAII)

Coronary Artery Disease

Spain
Accumetrics, Inc.

Completed

GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety (GRAVITAS)

Acute Coronary Syndrome | Coronary Arteriosclerosis

United States, Canada
The Hospital District of Satakunta

Unknown

Comparison of Bio-Active-Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome (BASE-ACS)

Acute Coronary Syndrome

Finland
Abbott Medical Devices

Completed

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ I)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Australia, Germany, France, Switzerland, Netherlands, United Kingdom, Portugal, Belgium, Denmark
Abbott Medical Devices

Completed

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe (SPIRIT V)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Ireland, Netherlands, Singapore, Spain, China, Belgium, Switzerland, Thailand, Israel, Germany, New Zealand, United Kingdom, Italy, Malaysia, Canada, India, Austria, France, South Africa, Portugal, Czech Republic, Greece, Sweden
Cordis Corporation

Completed

A Study of the Presillion Stent in de Novo Coronary Lesions (PRESILLION)

Coronary Artery Disease

Belgium
Centro de estudios en Cardiologia Intervencionista

Completed

Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents (ORAR III)

Coronary Heart Disease | Coronary Restenosis

Argentina
Centro de estudios en Cardiologia Intervencionista
Eucatech AG

Completed

A Trial Comparing a Paclitaxel Eluting Stent With Biodegradable Polymer Versus a Bare Metal Stent (EUCATAX)

Coronary Artery Disease

Argentina
Abbott Medical Devices

Completed

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United States, Switzerland, Netherlands, Spain, France, Sweden, Poland, Germany, Belgium, Denmark, Italy, United Kingdom
Uppsala University

Completed

Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis (TOPAS-1)

Myocardial Infarction | Heart Diseases | Coronary Artery Disease | Acute Coronary Syndrome | Stent Thrombosis

Sweden
University of Pecs

Terminated

Doubling the Maintenance Dose of Clopidogrel in Patients With High On-Clopidogrel Platelet Reactivity (DOSER)

Stable Angina Pectoris | Ad Hoc Percutaneous Coronary Intervention

Hungary
University Medical Center Groningen
Netherlands Heart Foundation

Unknown

Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Non-ST-elevation Myocardial Infarction Study (TAPAS II)

Non-ST-Elevation Myocardial Infarction

Netherlands
Liuhuaqiao Hospital

Unknown

Angiographic and Intravascular Ultrasound (IVUS) Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals (AIFSIDDES)

Drug Eluting Stent

China
Cedars-Sinai Medical Center

Unknown

Bridging Therapy in Patients at High Risk for Stent Thrombosis Undergoing Surgery

Thrombosis | Bleeding

United States
Lumen Biomedical

Completed

The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts (RETRIEVE)

Myocardial Ischemia | Embolism | Saphenous Vein Graft Disease

United States
University Hospital Freiburg

Unknown

Long-Term Safety of Drug Eluting Stents in the "Real World" (FReIburger STent Registry) (FRIST)

Stent Thrombosis
The Cleveland Clinic

Terminated

PeriOperative Bridging - Perioperative Anticoagulation in the Setting of Recent Intracoronary Drug Eluting Stents

Stent Thrombosis

United States
Cogentus Pharmaceuticals

Terminated

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) (COGENT-1)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention

United States, France, Canada, Australia, Poland, Germany, Italy, Mexico, Romania, Slovakia, Hungary, Czech Republic, Chile, Bulgaria, Puerto Rico, Ukraine
JW Medical Systems Ltd

Unknown

A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions (EVOLUTION)

Myocardial Infarction | Ischemia | Cardiac Death

China
Boston Scientific Corporation
KIKA

Completed

Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries (MELODIE)

Thrombosis | Intermittent Claudication | Arterial Occlusive Disease | Atherosclerotic Disease

Belgium, Canada, Czech Republic, Netherlands, Poland
Medical University of Vienna

Completed

Austrian Multivessel Taxus-Stent Registry (AUTAX)

Coronary Artery Disease

Austria
A.O. Ospedale Papa Giovanni XXIII
Boston Scientific Corporation; Medtronic Vascular; Case Western Reserve University

Unknown

Optical Coherence Tomography for Drug Eluting Stent Safety (ODESSA)

Coronary Artery Disease

Italy
National Heart, Lung, and Blood Institute (NHLBI)

Completed

MRI to Detect Embolism Following Angiography and Angioplasty-Stenting of the Renal Artery

Renal Artery Obstruction | Kidney Disease

United States
Providence Health & Services

Unknown

Retrospective Study of the Impact of Drug Eluting Stents

Coronary Artery Disease

United States
University of Michigan

Not yet recruiting

Improving Engagement With a Process Measure Dashboard Through Precision Feedback

Behavior

United States
Regeneron Pharmaceuticals

Not yet recruiting

A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants (ROXI-VTE II)

Venous Thromboembolism
University Hospital, Bordeaux

Recruiting

Grade Analysis of Veins by MRI and CT in Post-Thrombotic Syndrome (GrAVITSPT)

Lower Limb Venous Thrombosis

France
Ataturk University

Recruiting

Thrombophilia and Thrombosis in Behçet's Disease

Behçet Disease

Turkey
University Health Network, Toronto
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...

Not yet recruiting

TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study (T-REX HMB)

Venous Thromboembolism | Venous Thromboses | Anticoagulants and Bleeding Disorders | Heavy Menstrual Bleeding
Region Stockholm

Recruiting

Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents

Bile Duct Cancer | Duodenal Cancer | Pancreatic Cancer Non-resectable | Papillary Carcinoma

Sweden
Shanghai Zhongshan Hospital

Not yet recruiting

IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome (OPTION2)

Coronary Artery Disease
Fluidx Medical Technology, Inc.
Bright Research Partners

Not yet recruiting

Evaluation of a Simple-Prep Controlled Embolic (GPX)

Renal Cell Carcinoma | Embolism | Bone Tumor | Portal Vein Embolism | Renal Angiomyolipoma | Vascular Tumor
Medical University of South Carolina
National Cancer Institute (NCI)

Not yet recruiting

Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery

Cancer | Surgery | Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
Peking University First Hospital

Recruiting

Fractional Flow Reserve-guided Stenting Versus Medical Therapy in Atherosclerosis Renal Artery Stenosis (FAIR)

Renal Artery Stenosis Atherosclerotic | Secondary Hypertension Renal Arterial

China

Search clinical trials for: stent thrombosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations